explore -WSS

explore

author：entertainment 2025-10-01 00:58:05 - browse：89

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Midwives could help bridge maternal health disparities in the U.S.

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

PBMs drew scrutiny in House hearing — and so did pharma

Why the quest to eradicate polio has stumbled

Biogen’s boardroom scandal saddles CEO with first crisis

Transgender sports debate: Physicians say bans are health issue

Biden administration begins canceling student loan debt for 804,000 borrowers

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Heart attack and stroke risk calculators need revising

Transgender sports debate: Physicians say bans are health issue

Novavax promises a turnaround & Lilly roils the obesity market

Treatments for cramps don't cut it. Why aren't there better options?

Supreme Court strikes down use of affirmative action

Dozens dead from Maui wildfires: What we know about the victims

How one medical school became remarkably diverse

Idaho college killings prosecutors challenge defense's grand jury claims

New air purifier tech could be key to improving indoor air quality

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Wikipedia

Schizophrenia gene found to be linked to cells' energy dysfunction

Timeline: How the deadly wildfires took over Maui day by day

Senators push IRS to launch nonprofit hospital probe

Surge in Apellis stock fueled by confidence in safety of its eye drug

FDA panel to weigh safety of artificial wombs for preterm births

Dozens dead from Maui wildfires: What we know about the victims

hotspot

leisure time

Wikipedia

hotspot